Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Ropivacaine × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Thoracic 1 Genitourinary 1 Breast 1

Conditions

Breast Neoplasms 15 Pain, Postoperative 4 Chronic Pain 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Surgery 1 Breast Neoplasm Female 1 Breast Cancer Female 1 Agnosia 1

Interventions

Control Groups 3 Anesthetics, Local 3 Sodium Chloride 2 Magnesium Sulfate 2 Levobupivacaine 2 Dental Occlusion 2 Anesthesia, Local 2 Analgesics, Opioid 2 Transdermal Patch 1 Tramadol 1 Surveys and Questionnaires 1 S-Adenosylmethionine 1 Ropivacaine 1 Propofol 1 Pregabalin 1 Nerve Block 1 Musculoskeletal Manipulations 1 Lidocaine 1 Ketamine 1 High-Energy Shock Waves 1 Exercise Therapy 1 Drug Therapy 1 Capsaicin 1 Bupivacaine 1 Breathing Exercises 1 Botulinum Toxins, Type A 1 Anti-Inflammatory Agents, Non-Steroidal 1 Anesthesia, General 1 Anesthesia, Conduction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04824599 2023-09-07

Regional Anesthesia and Partial Mastectomy

Karlstad Central Hospital

Phase NA Completed

Agnosia, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡